InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Kazam Joshua A, Director. Officer active across 4 companies, notably TS Innovation Acquisitions Corp.. In total, 9 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €166k. History available since 10 June 2021. The latest transaction was disclosed on 18 December 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Joshua A. Kazam serves as a board member at TS Innovation Acquisitions Corp. and Allogene Therapeutics, Inc. He plays a key role in overseeing operations and making strategic decisions for these companies. His experience in biotechnology is essential for ensuring the growth and sustainability of these companies.